99 related articles for article (PubMed ID: 29304930)
1. Re: "Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project".
Malhotra A; Wu X; Tu L; Seifert K
J Am Coll Radiol; 2018 Jan; 15(1 Pt A):9. PubMed ID: 29304930
[No Abstract] [Full Text] [Related]
2. Author's Reply Re: Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project.
Dickerson EC; Davenport MS
J Am Coll Radiol; 2018 Jan; 15(1 Pt A):9-10. PubMed ID: 29304929
[No Abstract] [Full Text] [Related]
3. Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project.
Dickerson E; Davenport MS; Syed F; Stuve O; Cohen JA; Rinker JR; Goldman MD; Segal BM; Foerster BR;
J Am Coll Radiol; 2017 Mar; 14(3):371-379.e1. PubMed ID: 27932248
[TBL] [Abstract][Full Text] [Related]
4. Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
Zakaria R; Vajramani G; Westmoreland L; Fletcher N; Eldridge P; Alusi S; Osman-Farah J
Acta Neurochir (Wien); 2013 Dec; 155(12):2359-64; discussion 2364. PubMed ID: 23975649
[TBL] [Abstract][Full Text] [Related]
5. Clinically isolating syndrome: when neurology hits a neurologist.
Seachrist E
Pract Neurol; 2019 Oct; 19(5):449-450. PubMed ID: 31292240
[No Abstract] [Full Text] [Related]
6. Do MRI Structured Reports for Multiple Sclerosis Contain Adequate Information for Clinical Decision Making?
Alessandrino F; Pichiecchio A; Mallucci G; Ghione E; Romani A; Bergamaschi R; Bastianello S
AJR Am J Roentgenol; 2018 Jan; 210(1):24-29. PubMed ID: 28952814
[TBL] [Abstract][Full Text] [Related]
7. Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Del Piccolo L; Pietrolongo E; Radice D; Tortorella C; Confalonieri P; Pugliatti M; Lugaresi A; Giordano A; Heesen C; Solari A;
PLoS One; 2015; 10(6):e0127734. PubMed ID: 26030822
[TBL] [Abstract][Full Text] [Related]
8. An exploratory study of the electronic medical record and outpatient vascular neurology consultations.
Georgeon L; Gorelick PB; Raykov T; Farooq MU; Min J; Goshgarian C; Haveman-Gould B; Groenhout A; McCarthy M
Neurol Sci; 2017 Dec; 38(12):2195-2198. PubMed ID: 29022132
[TBL] [Abstract][Full Text] [Related]
9. Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists - a qualitative study.
Driedger SM; Maier R; Marrie RA; Brouwers M
BMC Neurol; 2017 Sep; 17(1):176. PubMed ID: 28882115
[TBL] [Abstract][Full Text] [Related]
10. Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients.
Heesen C; Kleiter I; Meuth SG; Krämer J; Kasper J; Köpke S; Gaissmaier W
J Neurol Sci; 2017 May; 376():181-190. PubMed ID: 28431609
[TBL] [Abstract][Full Text] [Related]
11. Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.
Lairy G; Zephir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; De Seze J
Rev Neurol (Paris); 2015 May; 171(5):407-14. PubMed ID: 25912471
[TBL] [Abstract][Full Text] [Related]
12. The emergence of multiple sclerosis, 1870-1950: a puzzle of historical epidemiology.
Talley CL
Perspect Biol Med; 2005; 48(3):383-95. PubMed ID: 16085995
[TBL] [Abstract][Full Text] [Related]
13. Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event.
Gout O; Lebrun-Frenay C; Labauge P; Le Page GE; Clavelou P; Allouche S;
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):323-5. PubMed ID: 21097550
[TBL] [Abstract][Full Text] [Related]
14. Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study.
Zecca C; Disanto G; Mühl S; Gobbi C
BMC Neurol; 2017 Sep; 17(1):171. PubMed ID: 28870152
[TBL] [Abstract][Full Text] [Related]
15. Access to multiple sclerosis diagnosis for Canadian neurologists.
O'Connor P; Lee L
Can J Neurol Sci; 1999 May; 26(2):115-8. PubMed ID: 10352870
[TBL] [Abstract][Full Text] [Related]
16. Importance of an individual's evaluation of functional status for health-related quality of life in patients with multiple sclerosis.
Gavelova M; Nagyova I; Rosenberger J; Krokavcova M; Gdovinova Z; Groothoff JW; van Dijk JP
Disabil Health J; 2015 Jul; 8(3):372-9. PubMed ID: 25981341
[TBL] [Abstract][Full Text] [Related]
17. [Re: Unethical of neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support].
Holmøy T; Myhr KM; Bø L
Tidsskr Nor Laegeforen; 2014 Dec; 134(23-24):2239-40. PubMed ID: 25492327
[No Abstract] [Full Text] [Related]
18. MR imaging field strength: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5 T.
Lee DH; Vellet AD; Eliasziw M; Vidito L; Ebers GC; Rice GP; Hewett L; Dunlavy S
Radiology; 1995 Jan; 194(1):257-62. PubMed ID: 7997564
[TBL] [Abstract][Full Text] [Related]
19. Disclosing a misdiagnosis of multiple sclerosis: do no harm?
Solomon AJ; Klein E
Continuum (Minneap Minn); 2013 Aug; 19(4 Multiple Sclerosis):1087-91. PubMed ID: 23917103
[TBL] [Abstract][Full Text] [Related]
20. Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Rae-Grant A; Bennett A; Sanders AE; Phipps M; Cheng E; Bever C
Neurology; 2015 Nov; 85(21):1904-8. PubMed ID: 26333795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
